STOCK TITAN

PolarityTE Announces Entry Into a Letter of Intent For Acquisition of the Company

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Rhea-AI Summary

PolarityTE (Nasdaq: PTE) announced a non-binding letter of intent with Michael Brauser for a proposed acquisition at $1.03 per share, entirely in cash. As of December 23, 2022, PolarityTE had 7,256,786 outstanding common shares and 256,457 restricted stock units. The deal's completion depends on due diligence, negotiation of definitive documents, and other closing conditions, with a deadline for negotiations set for March 15, 2022. Additionally, Brauser plans to cover outstanding warrants and severance payments totaling $2,595,000.

Positive
  • Potential acquisition could provide a cash influx to the company.
  • Proposed offering price of $1.03 may reflect a premium to current market value.
Negative
  • The transaction is non-binding, bringing uncertainty to its completion.
  • No assurance that a definitive agreement will be reached by the set deadline.
  • The company may face operational disruptions during the acquisition process.

SALT LAKE CITY, Dec. 27, 2022 /PRNewswire/ --  PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing regenerative tissue products and biomaterials (the "Company"), today announced that it signed a non-binding letter of intent (the "LOI") with Michael Brauser ("Brauser") for him to make an offer to acquire 100% of the outstanding equity interests of the Company at a proposed offering price of $1.03 per common share, which would be paid entirely in cash. As of December 23, 2022, there were 7,256,786 shares of the Company's common stock outstanding and unvested restricted stock units covering an additional 256,457 common shares. 

Completion of the transaction is subject to Brauser conducting due diligence investigations, the negotiation and execution of definitive transaction documents, Brauser successfully acquiring a majority of the outstanding common stock of the Company, and other customary closing conditions. The LOI provides that Brauser will pursue due diligence and the parties will endeavor to negotiate the terms of the definitive transaction documents during the period ending March 15, 2022 (the "Due Diligence Period"). There can be no assurance that a definitive agreement will be entered into by that date, if at all, or that the proposed transaction will be consummated.  Further, readers are cautioned that those portions of the LOI that describe the proposed transaction, including the offering price per common share, are non-binding and could be adjusted by the parties' mutual agreement during the Due Diligence Period.

At December 23, 2022, there were approximately 4,787,824 common stock purchase warrants outstanding that provide, in part, that upon a change in ownership of the Company's outstanding common stock greater than 50% and in connection therewith the Company ceases to file periodic reports with the Securities and Exchange Commission, then the holders of the warrants have the right to receive payment in cash of the value of the warrants determined under a formula stated in the agreements governing the warrants. The LOI contemplates that Brauser will make a capital contribution or loan to the Company in an amount required to settle cash payment of all the outstanding warrants in accordance with the terms of such warrants, except as otherwise provided in any separate agreement that Brauser may enter into with a warrant holder to accept a different amount.

The LOI also contemplates that the definitive transaction documents will provide that the aggregate severance payments under management employment contracts will not exceed $2,595,000 and that Brauser will, if necessary, make a capital contribution or loan to the Company in an amount required to make such severance payments at closing. 

Forward Looking Statements

Certain statements contained in this release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. They are generally identified by words such as "believes," "may," "expects," "anticipates," "intend," "plan," "will," "would," "should" and similar expressions. Such forward-looking statements include, but are not limited to, statements related to the letter of intent between the Company and Michael Brauser. Readers should not place undue reliance on such forward-looking statements.  Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties, many of which are beyond our control that may cause actual results or events to differ materially from those projected. These risks and uncertainties include the risk factors and other items described in more detail in the "Risk Factors" section of the Company's Annual Reports and other filings with the SEC (copies of which may be obtained at www.sec.gov).  Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.

POLARITYTE, the POLARITYTE logo, SKINTE, WHERE SELF REGENERATES SELF and WELCOME TO THE SHIFT are registered trademarks of PolarityTE, Inc.

CONTACTS

Investors:
PolarityTE Investor Relations
ir@PolarityTE.com
385-831-5284

Media:
David Schull or Ignacio Guerrero-Ros
David.schull@russopartnersllc.com 
Ignacio.guerrero-ros@russopartnersllc.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/polarityte-announces-entry-into-a-letter-of-intent-for-acquisition-of-the-company-301710003.html

SOURCE PolarityTE, Inc.

FAQ

What is the acquisition offer for PolarityTE by Michael Brauser?

Michael Brauser has offered to acquire PolarityTE at $1.03 per common share.

What conditions must be met for the acquisition of PolarityTE?

The acquisition is subject to due diligence, negotiation of definitive documents, and other customary closing conditions.

When is the deadline for negotiations regarding the acquisition of PolarityTE?

Negotiations must be concluded by March 15, 2022.

What financial obligations does Brauser plan to cover in the acquisition?

Brauser plans to cover outstanding warrants and severance payments totaling $2,595,000.

What are the risks associated with the acquisition of PolarityTE?

Key risks include the non-binding nature of the offer and no guarantee of a definitive agreement being reached.

PTE

NASDAQ:PTE

PTE Rankings

PTE Latest News

PTE Stock Data

1.78M
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
US
Salt Lake City